From Chemical to Drug

19.12.2016 | Alumni Chapter New England

Von:  Patrick Anquetil

The Alumni from New England Chapter were invited to attend a seminar organized by JLABS around drug discovery and development: From Chemical to Drug - The Path to a Small Molecule IND.

Dieser Text ist nicht übersetzt. Hier finden Sie den ganzen Artikel in Englisch.

New England Chapter Alumni @ JLABS
New England Chapter Alumni @ JLABS

JLABS is part of Johnson & Johnson Innovation, LLC, and is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. Industry experts from Johnson & Johnson presented best practices when filing small molecule investigational new drug applications. ETH Alumnus Daniel Schaufelberger, Sr. Scientific Director, Portfolio Management, Janssen R&D,  and lead coordinator of the ETH Alumni North America Chapters helped organize the event and presented a talk explaining the method of drug development. The event was well attended and a captivated audience asked pertinent questions on how to reduce this knowledge to practice.

For more informations about the Alumni New England Chapter:

http://www.ethalumninec.org/

 
 
URL der Seite: http://www.alumni.ethz.ch/news-und-medien/news/2016/12/from-chemical-to-drug.html
Thu Mar 23 07:14:06 CET 2017
© 2017 Eidgenössische Technische Hochschule Zürich